Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients wi...
Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload
About this item
Full title
Author / Creator
Smith, Gillian C , Alpendurada, Francisco , Carpenter, John Paul , Alam, Mohammed H , Berdoukas, Vasili , Karagiorga, Markissia , Ladis, Vasili , Piga, Antonio , Aessopos, Athanassios , Gotsis, Efstathios D , Tanner, Mark A , Westwood, Mark A , Galanello, Renzo , Roughton, Michael and Pennell, Dudley J
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Thalassaemia major (TM) patients need regular blood transfusions that lead to accumulation of iron and death from heart failure. Deferiprone has been reported to be superior to deferoxamine for the removal of cardiac iron and improvement in left ventricular (LV) function but little is known of their relative effects on the right ventricle (RV), whi...
Alternative Titles
Full title
Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_ec766fa915e44de8a77414ecc2fa83fb
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ec766fa915e44de8a77414ecc2fa83fb
Other Identifiers
ISSN
1097-6647,1532-429X
E-ISSN
1532-429X
DOI
10.1186/1532-429X-13-34
